Edwards Lifesciences Corporation Total Debt 2008–2025
Edwards Lifesciences Corporation reported $598.30M of total debt (short- plus long-term borrowings) for fiscal 2025. That was 0.1% higher than fiscal 2024. Compared with fiscal 2020, the change was +0.6%.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $598.30M | +0.1% |
| FY 2024 | $597.70M | +0.1% |
| FY 2023 | $597.00M | +0.1% |
| FY 2022 | $596.30M | +0.1% |
| FY 2021 | $595.70M | +0.1% |
| FY 2020 | $595.00M | +0.1% |
| FY 2019 | $594.40M | +0.1% |
| FY 2018 | $593.80M | +35.4% |
| FY 2017 | $438.40M | -46.7% |
| FY 2016 | $822.30M | +37.8% |
| FY 2015 | $596.90M | -0.2% |
| FY 2014 | $598.10M | -0.3% |
| FY 2013 | $600.00M | +217.0% |
| FY 2012 | $189.30M | — |
| FY 2011 | $0 | — |
| FY 2010 | $0 | -100.0% |
| FY 2009 | $90.30M | — |
| FY 2008 | $0 | — |
Source: Edwards Lifesciences Corporation SEC filings — balance sheet (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open EW 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Edwards Lifesciences Corporation reported $598.30M of total debt (short- plus long-term borrowings) for fiscal 2025. That was 0.1% higher than fiscal 2024. Compared with fiscal 2020, the change was +0.6%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Edwards Lifesciences Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeEdwards Lifesciences Corporation — frequently asked questions
What is Edwards Lifesciences Corporation's total debt (short- plus long-term borrowings)?
Edwards Lifesciences Corporation (EW) reported total debt (short- plus long-term borrowings) of $598.30M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Edwards Lifesciences Corporation's official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.